Systemic Administration of 17β-Estradiol Reduces Apoptotic Cell Death and Improves Functional Recovery Following Traumatic Spinal Cord Injury in Rats

Tae Y. Yune, Sun J. Kim, Sang M. Lee, Young K. Lee, Young Jun Oh, Young C. Kim, George J. Markelonis, Tae H. Oh

Research output: Contribution to journalArticle

104 Citations (Scopus)

Abstract

Recent evidence indicates that estrogen exerts neuroprotective effects in both brain injury and neurodegenerative diseases. We examined the protective effect of estrogen on functional recovery after spinal cord injury (SCI) in rats. 17β-estradiol (3, 100, or 300μg/kg) was administered intravenously 1-2 h prior to injury (pre-treatment), and animals were then subjected to a mild, weight-drop spinal cord contusion injury. Estradiol treatment significantly improved hind limb motor function as determined by the Basso-Beattie-Bresnahan (BBB) locomotor open field behavioral rating test. Fifteen to 30 days after SCI, BBB scores were significantly higher in estradiol-treated (100 μg/kg) rats when compared to vehicle-treated rats. Morphological analysis showed that lesion sizes increased progressively in either vehicle-treated or 17β-estradiol-treated spinal cords. However, in response to treatment with 17β-estradiol, the lesion size was significantly reduced 18-28 days after SCI when compared to vehicle-treated controls. Terminal deoxynucleotidyl transferase-mediated UTP nick-end labeling (TUNEL) staining and DNA gel electrophoresis revealed that apoptotic cell death peaked 24-48 h after injury. Also, SCI induced a marked increase in activated caspase-3 in the spinal cord, evident by 4 h after injury. However, administration of 17β-estradiol significantly reduced the SCI-induced increase in apoptotic cell death and caspase-3 activity after SCI. Furthermore, 17β-estradiol significantly increased expression of the anti-apoptotic genes, bcl-2 and bcl-x, after SCI while expression of the pro-apoptotic genes, bad and bax, was not affected by drug treatment. Finally, intravenous administration of 17β-estradiol (100 μg/kg) immediately after injury (post-treatment) also significantly improved hind limb motor function 19-30 days after SCI compared to vehicle-treated controls. These data suggest that after SCI, 17β-estradiol treatment improved functional recovery in the injured rat, in part, by reducing apoptotic cell death.

Original languageEnglish
Pages (from-to)293-306
Number of pages14
JournalJournal of Neurotrauma
Volume21
Issue number3
DOIs
Publication statusPublished - 2004 Mar 1

Fingerprint

Spinal Cord Injuries
Estradiol
Cell Death
Wounds and Injuries
Caspase 3
Spinal Cord
Estrogens
Therapeutics
Extremities
bcl-2 Genes
Uridine Triphosphate
DNA Nucleotidylexotransferase
Brain Diseases
Neuroprotective Agents
Neurodegenerative Diseases
Intravenous Administration
Brain Injuries
Electrophoresis
Gels
Staining and Labeling

All Science Journal Classification (ASJC) codes

  • Clinical Neurology

Cite this

Yune, Tae Y. ; Kim, Sun J. ; Lee, Sang M. ; Lee, Young K. ; Oh, Young Jun ; Kim, Young C. ; Markelonis, George J. ; Oh, Tae H. / Systemic Administration of 17β-Estradiol Reduces Apoptotic Cell Death and Improves Functional Recovery Following Traumatic Spinal Cord Injury in Rats. In: Journal of Neurotrauma. 2004 ; Vol. 21, No. 3. pp. 293-306.
@article{136c0e5ba28d4386bc6568cbea6928a9,
title = "Systemic Administration of 17β-Estradiol Reduces Apoptotic Cell Death and Improves Functional Recovery Following Traumatic Spinal Cord Injury in Rats",
abstract = "Recent evidence indicates that estrogen exerts neuroprotective effects in both brain injury and neurodegenerative diseases. We examined the protective effect of estrogen on functional recovery after spinal cord injury (SCI) in rats. 17β-estradiol (3, 100, or 300μg/kg) was administered intravenously 1-2 h prior to injury (pre-treatment), and animals were then subjected to a mild, weight-drop spinal cord contusion injury. Estradiol treatment significantly improved hind limb motor function as determined by the Basso-Beattie-Bresnahan (BBB) locomotor open field behavioral rating test. Fifteen to 30 days after SCI, BBB scores were significantly higher in estradiol-treated (100 μg/kg) rats when compared to vehicle-treated rats. Morphological analysis showed that lesion sizes increased progressively in either vehicle-treated or 17β-estradiol-treated spinal cords. However, in response to treatment with 17β-estradiol, the lesion size was significantly reduced 18-28 days after SCI when compared to vehicle-treated controls. Terminal deoxynucleotidyl transferase-mediated UTP nick-end labeling (TUNEL) staining and DNA gel electrophoresis revealed that apoptotic cell death peaked 24-48 h after injury. Also, SCI induced a marked increase in activated caspase-3 in the spinal cord, evident by 4 h after injury. However, administration of 17β-estradiol significantly reduced the SCI-induced increase in apoptotic cell death and caspase-3 activity after SCI. Furthermore, 17β-estradiol significantly increased expression of the anti-apoptotic genes, bcl-2 and bcl-x, after SCI while expression of the pro-apoptotic genes, bad and bax, was not affected by drug treatment. Finally, intravenous administration of 17β-estradiol (100 μg/kg) immediately after injury (post-treatment) also significantly improved hind limb motor function 19-30 days after SCI compared to vehicle-treated controls. These data suggest that after SCI, 17β-estradiol treatment improved functional recovery in the injured rat, in part, by reducing apoptotic cell death.",
author = "Yune, {Tae Y.} and Kim, {Sun J.} and Lee, {Sang M.} and Lee, {Young K.} and Oh, {Young Jun} and Kim, {Young C.} and Markelonis, {George J.} and Oh, {Tae H.}",
year = "2004",
month = "3",
day = "1",
doi = "10.1089/089771504322972086",
language = "English",
volume = "21",
pages = "293--306",
journal = "Journal of Neurotrauma",
issn = "0897-7151",
publisher = "Mary Ann Liebert Inc.",
number = "3",

}

Systemic Administration of 17β-Estradiol Reduces Apoptotic Cell Death and Improves Functional Recovery Following Traumatic Spinal Cord Injury in Rats. / Yune, Tae Y.; Kim, Sun J.; Lee, Sang M.; Lee, Young K.; Oh, Young Jun; Kim, Young C.; Markelonis, George J.; Oh, Tae H.

In: Journal of Neurotrauma, Vol. 21, No. 3, 01.03.2004, p. 293-306.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Systemic Administration of 17β-Estradiol Reduces Apoptotic Cell Death and Improves Functional Recovery Following Traumatic Spinal Cord Injury in Rats

AU - Yune, Tae Y.

AU - Kim, Sun J.

AU - Lee, Sang M.

AU - Lee, Young K.

AU - Oh, Young Jun

AU - Kim, Young C.

AU - Markelonis, George J.

AU - Oh, Tae H.

PY - 2004/3/1

Y1 - 2004/3/1

N2 - Recent evidence indicates that estrogen exerts neuroprotective effects in both brain injury and neurodegenerative diseases. We examined the protective effect of estrogen on functional recovery after spinal cord injury (SCI) in rats. 17β-estradiol (3, 100, or 300μg/kg) was administered intravenously 1-2 h prior to injury (pre-treatment), and animals were then subjected to a mild, weight-drop spinal cord contusion injury. Estradiol treatment significantly improved hind limb motor function as determined by the Basso-Beattie-Bresnahan (BBB) locomotor open field behavioral rating test. Fifteen to 30 days after SCI, BBB scores were significantly higher in estradiol-treated (100 μg/kg) rats when compared to vehicle-treated rats. Morphological analysis showed that lesion sizes increased progressively in either vehicle-treated or 17β-estradiol-treated spinal cords. However, in response to treatment with 17β-estradiol, the lesion size was significantly reduced 18-28 days after SCI when compared to vehicle-treated controls. Terminal deoxynucleotidyl transferase-mediated UTP nick-end labeling (TUNEL) staining and DNA gel electrophoresis revealed that apoptotic cell death peaked 24-48 h after injury. Also, SCI induced a marked increase in activated caspase-3 in the spinal cord, evident by 4 h after injury. However, administration of 17β-estradiol significantly reduced the SCI-induced increase in apoptotic cell death and caspase-3 activity after SCI. Furthermore, 17β-estradiol significantly increased expression of the anti-apoptotic genes, bcl-2 and bcl-x, after SCI while expression of the pro-apoptotic genes, bad and bax, was not affected by drug treatment. Finally, intravenous administration of 17β-estradiol (100 μg/kg) immediately after injury (post-treatment) also significantly improved hind limb motor function 19-30 days after SCI compared to vehicle-treated controls. These data suggest that after SCI, 17β-estradiol treatment improved functional recovery in the injured rat, in part, by reducing apoptotic cell death.

AB - Recent evidence indicates that estrogen exerts neuroprotective effects in both brain injury and neurodegenerative diseases. We examined the protective effect of estrogen on functional recovery after spinal cord injury (SCI) in rats. 17β-estradiol (3, 100, or 300μg/kg) was administered intravenously 1-2 h prior to injury (pre-treatment), and animals were then subjected to a mild, weight-drop spinal cord contusion injury. Estradiol treatment significantly improved hind limb motor function as determined by the Basso-Beattie-Bresnahan (BBB) locomotor open field behavioral rating test. Fifteen to 30 days after SCI, BBB scores were significantly higher in estradiol-treated (100 μg/kg) rats when compared to vehicle-treated rats. Morphological analysis showed that lesion sizes increased progressively in either vehicle-treated or 17β-estradiol-treated spinal cords. However, in response to treatment with 17β-estradiol, the lesion size was significantly reduced 18-28 days after SCI when compared to vehicle-treated controls. Terminal deoxynucleotidyl transferase-mediated UTP nick-end labeling (TUNEL) staining and DNA gel electrophoresis revealed that apoptotic cell death peaked 24-48 h after injury. Also, SCI induced a marked increase in activated caspase-3 in the spinal cord, evident by 4 h after injury. However, administration of 17β-estradiol significantly reduced the SCI-induced increase in apoptotic cell death and caspase-3 activity after SCI. Furthermore, 17β-estradiol significantly increased expression of the anti-apoptotic genes, bcl-2 and bcl-x, after SCI while expression of the pro-apoptotic genes, bad and bax, was not affected by drug treatment. Finally, intravenous administration of 17β-estradiol (100 μg/kg) immediately after injury (post-treatment) also significantly improved hind limb motor function 19-30 days after SCI compared to vehicle-treated controls. These data suggest that after SCI, 17β-estradiol treatment improved functional recovery in the injured rat, in part, by reducing apoptotic cell death.

UR - http://www.scopus.com/inward/record.url?scp=1642482615&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1642482615&partnerID=8YFLogxK

U2 - 10.1089/089771504322972086

DO - 10.1089/089771504322972086

M3 - Article

C2 - 15115604

AN - SCOPUS:1642482615

VL - 21

SP - 293

EP - 306

JO - Journal of Neurotrauma

JF - Journal of Neurotrauma

SN - 0897-7151

IS - 3

ER -